ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BB01 | B | Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml | 10277 | 121320/1 | INFLUVAC TETRA | 1x0.5ml | Injectable suspension | IM/SC | Mersaco | Abbott Biologicals BV | The Netherlands | 970,254 L.L | 23.08 | A2 | Abbott Biologicals BV | The Netherlands | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BB01 | B | Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml | 9809 | 21919/1 | VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE) | 1x0.5ml | Injectable suspension | IM/SC | Mersaco | Sanofi Pasteur SA | France | 970,254 L.L | 23.08 | A2 | Sanofi Pasteur SA | France | 2/5/2024 | 0 |